Get the Stockscreener App
270.33
1.46%
3.88
Overview
News
Price History
Option Chain
Financials
Why DHR Down?
Discussions
Forecast
Stock Split
Dividend History
Danaher Corp stock is traded at $270.33, with a volume of 1.70M.
It is up +1.46% in the last 24 hours and down -0.61% over the past month.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
See More
Previous Close:
$266.45
Open:
$267.64
24h Volume:
1.70M
Relative Volume:
0.74
Market Cap:
$195.24B
Revenue:
$21.11B
Net Income/Loss:
$4.20B
P/E Ratio:
34.09
EPS:
7.93
Net Cash Flow:
$5.08B
1W Performance:
+0.11%
1M Performance:
-0.61%
6M Performance:
+10.79%
1Y Performance:
+24.90%
1-Day Range:
$267.12
$272.15
1-Week Range:
$265.50
$272.15
52-Week Range:
$182.09
$281.70
Danaher Corp Stock (DHR) Company Profile
Name
Danaher Corp
Sector
Industry
Phone
(202) 828-0850
Address
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-23 | Initiated | HSBC Securities | Hold |
| Dec-13-23 | Resumed | Wolfe Research | Peer Perform |
| Dec-07-23 | Downgrade | Goldman | Buy → Neutral |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-01-23 | Initiated | SVB Securities | Outperform |
| Apr-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-18-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Oct-24-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-17-22 | Resumed | Bernstein | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jun-01-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-11-22 | Initiated | Bernstein | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-10-21 | Reiterated | BofA Securities | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Reiterated | Goldman | Buy |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Apr-07-21 | Resumed | Robert W. Baird | Outperform |
| Mar-03-21 | Resumed | Barclays | Overweight |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-02-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-26-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-03-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Resumed | Stifel | Hold |
| Oct-28-19 | Reiterated | Needham | Buy |
| Oct-14-19 | Resumed | Credit Suisse | Outperform |
| Jul-19-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Feb-25-19 | Upgrade | Janney | Neutral → Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Apr-20-18 | Reiterated | Stifel | Buy |
View All
Danaher Corp Stock (DHR) Latest News
Danaher Corp. stock rises Friday, outperforms market - MarketWatch
Danaher to Benefit From Business Strength Amid Headwinds - Yahoo Finance
Global Tissue Diagnostics Market is Expected to Develop at a Moderate 6.6% CAGR through 2031 | SkyQuest Technology - Benzinga
Danaher Corp. stock falls Thursday, underperforms market - MarketWatch
Danaher Corp. stock rises Wednesday, still underperforms market - MarketWatch
Chromatography Market Growth in Future Scope 2024-2031 | - openPR
Danaher Corp. stock rises Tuesday, still underperforms market - MarketWatch
Atomi Financial Group Inc. Grows Stake in Danaher Co. (NYSE:DHR) - MarketBeat
Cell Culture Market to Surpass Market Valuation of USD 74.52 Billion by 2031 | SkyQuest Technology - Benzinga
(DHR) Trading Signals - Stock Traders Daily
Danaher Corp. stock falls Monday, still outperforms market - MarketWatch
Global In-Vitro Diagnostics Market Size to Hit USD 202.91 Billion by 2033 | Straits Research - GlobeNewswire Inc.
U.S. Multiomics Market Trends Analysis Report 2024-2030: Increasing Demand for Personalized Medicines, Growing Prevalence of Chronic Diseases, and Rising Application in Drug Discovery & Development - GlobeNewswire Inc.
Beckman Coulter Life Sciences Names Joe Fox President - Technology Networks
Park Avenue Securities LLC Lowers Stock Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Corp. stock falls Friday, underperforms market - MarketWatch
Is Danaher Corporation (NYSE:DHR) The Top Goldman Sachs Fund Manager Stock Pick? - Insider Monkey
Is Danaher Corporation (NYSE:DHR) The Top Goldman Sachs Fund Manager Stock Pick? - Yahoo Finance
Danaher Co. (NYSE:DHR) Shares Bought by Healthcare of Ontario Pension Plan Trust Fund - MarketBeat
What You Need to Know Ahead of Danaher's Earnings Release - MSN
What You Need To Know Ahead Of Danaher's Earnings Release - Barchart
Danaher Co. (NYSE:DHR) Expected to Post FY2026 Earnings of $9.56 Per Share - MarketBeat
Treponema Pallidum Tests Market is Projected to Reach US$ 360 Million by 2034, According to New Report by Fact.MR - GlobeNewswire Inc.
Sanctuary Advisors LLC Acquires New Stake in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Corp. stock falls Wednesday, underperforms market - MarketWatch
Wolfe Research Initiates Coverage of Danaher (DHR) with Peer Perform Recommendation - MSN
The Zacks Analyst Blog Highlights McDonald's, Danaher, S&P Global, Twin Disc and Cato - Yahoo Finance
KP Management LLC Sells 3,000 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Top Stock Reports for McDonald's, Danaher & S&P Global - Yahoo Finance
Beckman Coulter Life Sciences hires president from Danaher’s Sciex - Medical Design & Outsourcing
Danaher price target raised to $278 from $275 at Evercore ISI - TipRanks
Danaher (NYSE:DHR) Now Covered by Analysts at Stephens - MarketBeat
Truist Financial Corp Sells 4,418 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
7 Best Medical Device Stocks To Buy Right Now - Insider Monkey
Cepheid Drives Danaher Corporation (DHR) Q2 2024 Success, Hedge Funds Rally Around the Stock - Insider Monkey
Cepheid Drives Danaher Corporation (DHR) Q2 2024 Success, Hedge Funds Rally Around the Stock - Yahoo Finance
Telesis Bio partners with Danaher company Beckman Coulter - MSN
Magnolia Capital Advisors LLC Acquires Shares of 19,874 Danaher Co. (NYSE:DHR) - MarketBeat
HSBC Initiates Coverage of Danaher (DHR) with Hold Recommendation - MSN
Danaher Co. (NYSE:DHR) Shares Sold by AQR Capital Management LLC - MarketBeat
Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)? - Simply Wall St
Danaher Co. (NYSE:DHR) Shares Bought by MBB Public Markets I LLC - Defense World
Legal & General Group Plc Boosts Stake in Danaher Co. (NYSE:DHR) - Defense World
Wall Street SWOT: Danaher stock navigates high expectations amid diagnostic sector growth - Investing.com
Scientech Research LLC Has $1.66 Million Position in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Corporation (DHR): Why Are Billionaires Bullish on This Stock Right Now? - Yahoo Finance
Single-use Bioreactors Market Size is Set to Grow to USD 6.7 Billion by 2034 with a CAGR of 10.8% , Driven by Demand in Food and Industrial Biotechnology | Exclusive Report by Transparency Market Research Inc. - GlobeNewswire Inc.
November 8th Options Now Available For Danaher (DHR) - Nasdaq
Blotting Systems Market Competition & Segment Analysis – Advansta Inc., Bio-Rad Laboratories, Bio-Techne Corporation, Cell Signaling Technology, Danaher Corporation – Cauverynews - Cauverynews
Dorsey Asset Management LLC Has $76.56 Million Stock Position in Danaher Co. (NYSE:DHR) - MarketBeat
10 Best Stocks To Invest In According to Billionaires - Insider Monkey
Danaher Corp Stock (DHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Danaher Corp Stock (DHR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Couchara Georgeann | SVP, Human Resources |
Aug 26 '24 |
Sale |
268.37 |
952 |
255,483 |
4,212 |
0.53%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):